ArticleJAAD case reports2026

Stapokibart, a novel monoclonal antibody targeting the interleukin 4 receptor α subunit: Promising results in a retrospective cohort of patients with bullous pemphigoid.

Shufen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.